These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17219759)

  • 1. Closed-form confidence intervals on measures of precision for an interlaboratory study.
    Nijhuis MB; van den Heuvel ER
    J Biopharm Stat; 2007; 17(1):123-42. PubMed ID: 17219759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical inference for the within-device precision of quantitative measurements in assay validation.
    Liu JP; Lu LT; Liao CT
    J Biopharm Stat; 2009 Sep; 19(5):763-78. PubMed ID: 20183442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modified large-sample approach to approximate interval estimation for a particular intraclass correlation coefficient.
    Cappelleri JC; Ting N
    Stat Med; 2003 Jun; 22(11):1861-77. PubMed ID: 12754721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-sided tolerance intervals for balanced and unbalanced random effects models.
    Hoffman D; Kringle R
    J Biopharm Stat; 2005; 15(2):283-93. PubMed ID: 15796296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of confidence interval methods for the intraclass correlation coefficient in cluster randomized trials.
    Ukoumunne OC
    Stat Med; 2002 Dec; 21(24):3757-74. PubMed ID: 12483765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variance and confidence limits in validation studies based on comparison between three different types of measurements.
    Ferrari P; Kaaks R; Riboli E
    J Epidemiol Biostat; 2000; 5(5):303-13. PubMed ID: 11142606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the equivalence test for analytical method transfers: testing precision using the United States Pharmacopoeia concept (1010).
    Schepers U; Wätzig H
    J Pharm Biomed Anal; 2006 Apr; 41(1):290-2. PubMed ID: 16338114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and analysis of analytical method transfer studies.
    Schwenke JR; O'Connor DK
    J Biopharm Stat; 2008; 18(5):1013-33. PubMed ID: 18781533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical assessment of analytical method transfer.
    Zhong J; Lee K; Tsong Y
    J Biopharm Stat; 2008; 18(5):1005-12. PubMed ID: 18781532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events.
    Bradburn MJ; Deeks JJ; Berlin JA; Russell Localio A
    Stat Med; 2007 Jan; 26(1):53-77. PubMed ID: 16596572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical power and analytical quantification.
    Araujo P; Frøyland L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 847(2):305-8. PubMed ID: 17070737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confidence intervals and sample-size calculations for the sisterhood method of estimating maternal mortality.
    Hanley JA; Hagen CA; Shiferaw T
    Stud Fam Plann; 1996; 27(4):220-7. PubMed ID: 8875734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model for the statistical description of analytical errors occurring in clinical chemical laboratories with time.
    Hyvärinen A
    Scand J Clin Lab Invest Suppl; 1985; 175():1-84. PubMed ID: 3858970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical method transfer: new descriptive approach for acceptance criteria definition.
    de Fontenay G
    J Pharm Biomed Anal; 2008 Jan; 46(1):104-12. PubMed ID: 17961955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the recovery spread in analytical development and routine quality control--based on the ICH quality guideline Q2B.
    Schepers U; El Deeb S; Ermer J; Wätzig H
    J Pharm Biomed Anal; 2007 Jan; 43(2):708-10. PubMed ID: 16904281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncertainties of method performance statistics based on a balanced completely randomized model interlaboratory study.
    McClure FD; Lee JK
    J AOAC Int; 2008; 91(3):660-9. PubMed ID: 18567314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision of the reportable value-Statistical optimization of the number of replicates.
    Burdick RK; Ermer J
    J Pharm Biomed Anal; 2019 Jan; 162():149-157. PubMed ID: 30240988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the bootstrap in analysing cost data from cluster randomised trials: some simulation results.
    Flynn TN; Peters TJ
    BMC Health Serv Res; 2004 Nov; 4(1):33. PubMed ID: 15550169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining the error of dose estimates and minimum and maximum acceptable concentrations from assays with nonlinear dose-response curves.
    Gottschalk PG; Dunn JR
    Comput Methods Programs Biomed; 2005 Dec; 80(3):204-15. PubMed ID: 16256244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.